PT  - JOURNAL ARTICLE
AU  - Hoyle, Brian
ED  - McDonnell, Mary Ann A.
TI  - CEES
DP  - 2015 Sep 11
TA  - MD Conference Express
PG  - 7--7
VI  - 15
IP  - 11
4099  - http://mdc.sagepub.com/content/15/11/7.2.short
4100  - http://mdc.sagepub.com/content/15/11/7.2.full
AB  - A 6-week, open-label trial of a controlled-release formulation of the central nervous system stimulant methylphenidate achieved a dose that, when delivered in the evening, lessens attention deficit hyperactivity disorder symptoms in the morning in children aged 6 to 12 years. Moreover, symptoms are controlled for much of the remaining day.